William Blair & Company’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
William Blair & Company's MXCT Position: Q2 2026 in Review
William Blair & Company reduced its MaxCyte (MXCT) stake by 11% in Q2 2026, selling an estimated $1.44K and leaving 12,069 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1885.
William Blair & Company first reported a position in MXCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.2M in Q4 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- William Blair & Company held 12,069 shares of MaxCyte worth $14.8K as of Q2 2026.
- William Blair & Company sold 1,447 MaxCyte shares in Q2 2026, an estimated $1.44K.
- MaxCyte made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1885 holding.
- William Blair & Company first reported a position in MaxCyte in Q4 2021 and has held it in 19 quarters since.
- William Blair & Company's MaxCyte position peaked at $1.2M in Q4 2023.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.